Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
2002

Effects of Aplidine on Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Erba E, Bassano L, Di Liberti G, Muradore I, Chiorino G, Ubezio P, Vignati S, Codegoni A, Desiderio M A, Faircloth G, Jimeno J, D'Incalci M

Primary Institution: Cancer Pharmacology Laboratory, Department of Oncology, Istituto di Ricerche Farmacologiche “Mario Negri”

Hypothesis

What are the mechanisms involved in the Aplidine-induced antiproliferative effect, cell cycle perturbations, and cell death in human Molt-4 leukaemia cells?

Conclusion

Aplidine induces significant cell cycle perturbations and apoptosis in human leukaemia cells at very low concentrations.

Supporting Evidence

  • Aplidine was found to be cytotoxic at nanomolar concentrations.
  • The drug induced both a G1 arrest and a G2 blockade in cancer cells.
  • Cell cycle perturbations and apoptosis occurred without significant inhibition of macromolecular synthesis.

Takeaway

Aplidine is a drug that can stop cancer cells from growing and make them die, even in very small amounts.

Methodology

The study evaluated the cytotoxic effect of Aplidine on Molt-4 cells by exposing them to the drug and counting the cells at different time intervals after drug washout.

Limitations

The exact mechanism of action of Aplidine remains unclear, and the study does not provide a definitive explanation for its biological effects.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600265

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication